FDA Recall Terminated Historical recordClass II
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
- Reason
- Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
- Published
- June 20, 2012
- Distribution
- Nationwide
